Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  KOREA EXCHANGE  >  Samsung Biologics Co Ltd    207940   KR7207940008

SAMSUNG BIOLOGICS CO LTD

(207940)
My previous session
Most popular
  Report  
SummaryNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsAnalyst Recommendations

Samsung Biologics : S. Korean stocks close highest in about 3 weeks

share with twitter share with LinkedIn share with facebook
share via e-mail
0
01/12/2019 | 04:42am EDT

South Korean stocks gained ground on Friday.

The benchmark Korea Composite Stock Price Index (KOSPI) gained 12.29 points, or 0.60 percent, to settle at 2,075.57. Trading volume stood at 372.5 million shares worth 4.5 trillion won (4 billion U.S. dollars).

It was the highest close in about three weeks.

Many of blue-chip stocks ended in positive territory. Market bellwether Samsung Electronics rose 1.8 percent, and leading chemical firm LG Chem added 0.6 percent. Samsung BioLogics, a biopharmaceutical unit of Samsung Group, the country`s biggest family-controlled conglomerate, climbed 1.9 percent.

The state-run power supplier Korea Electric Power Corp. gained 0.7 percent, but memory chip giant SK Hynix dipped 0.3 percent. The biggest mobile operator SK Telecom declined 2.8 percent, and the biggest steelmaker POSCO lost 1.2 percent.

South Korea`s currency finished at 1,116.4 won against the greenback, up 1.9 won from the previous close.

Bond prices ended lower. Yields on the liquid three-year treasury notes added 0.8 basis points to 1.804 percent, and the return on the 10-year government bonds went up 2.8 basis points to 1.992 percent.

(c) 2019 ITP Business Publishing Ltd. All Rights Reserved. Provided by SyndiGate Media Inc. (Syndigate.info)., source Middle East & North African Newspapers

Stocks mentioned in the article
ChangeLast1st jan.
KOREA ELECTRIC POWER CORPORATION End-of-day quote.
SAMSUNG BIOLOGICS CO LTD End-of-day quote.
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on SAMSUNG BIOLOGICS CO LTD
03/16SAMSUNG BIOLOGICS : Prosecutors raid Seoul bourse in Samsung BioLogics probe
AQ
03/14South Korean prosecutors raid exchange in Samsung BioLogics probe - bourse of..
RE
01/29SAMSUNG BIOLOGICS : South Korea watchdog says to appeal court move to suspend Sa..
RE
01/24SAMSUNG BIOLOGICS : Court suspends FSC's penalties on Samsung BioLogics
AQ
01/22SAMSUNG BIOLOGICS : South Korean court suspends regulator's disciplinary action ..
RE
01/18Samsung Bioepis biosimilar to Roche's Herceptin wins FDA nod
RE
01/12SAMSUNG BIOLOGICS : S. Korean stocks close highest in about 3 weeks
AQ
2018KYUNG NAM PHARM : Samsung too big to kill, Kyung Nam Pharm weak enough to kill?
AQ
2018SAMSUNG BIOLOGICS : Prosecutors raid Samsung BioLogics headquarters
AQ
2018SAMSUNG BIOLOGICS : South Korea launches raid on Samsung firm amid fraud probe
AQ
More news
Financials (KRW)
Sales 2019 703 B
EBIT 2019 98,4 B
Net income 2019 111 B
Finance 2019 277 B
Yield 2019 -
P/E ratio 2019 234,92
P/E ratio 2020 80,09
EV / Sales 2019 31,5x
EV / Sales 2020 20,5x
Capitalization 22 397 B
Chart SAMSUNG BIOLOGICS CO LTD
Duration : Period :
Samsung Biologics Co Ltd Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 12
Average target price 480 000  KRW
Spread / Average Target 42%
EPS Revisions
Managers
NameTitle
Tae-Han Kim Chief Executive Officer & Director
Ho-Yeol Yoon Managing Director & Head-Operations Support
Dong-Joong Kim Director & Head-Management Support
Seok-Woo Jung Outside Director
Byeong-Cheol Yoon Outside Director
Sector and Competitors
1st jan.Capitalization (M$)
SAMSUNG BIOLOGICS CO LTD19 732
CSL LIMITED6.50%63 534
BIOGEN-27.98%42 629
ALEXION PHARMACEUTICALS33.74%29 098
GRIFOLS2.53%16 228
BIOMARIN PHARMACEUTICAL INC.3.41%15 706